Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration.
Pasqualetti F, Gonnelli A, Molinari A, Cantarella M, Montrone S, Cristaudo A, Baldaccini D, Mattioni R, Delishaj D, Mazzotti V, Morganti R, Cocuzza P, Fabrini MG, Lombardi G, Rudà R, Soffietti R, Paiar F.
Pasqualetti F, et al. Among authors: cristaudo a.
Anticancer Res. 2018 Oct;38(10):5877-5881. doi: 10.21873/anticanres.12930.
Anticancer Res. 2018.
PMID: 30275213